Exhibit 99.1

MATERIAL CHANGE REPORT

Form 51-102F3

Item 1 Name and Address of Company

Titan Medical Inc. (the “Company” or “Titan”)

155 University Avenue

Suite 750

Toronto, Ontario

M5H 3B7

Item 2 Date of Material Change

June 3, 2020.

Item 3 News Release

Attached as Schedule “A” hereto is a copy of a news release relating to the material change, which was disseminated on June 4, 2020, through Business Wire. The news release was subsequently filed on the System for Electronic Document Analysis and Retrieval at www.sedar.com.

Item 4 Summary of Material Change

On June 3, 2020, the Company entered into a development and license agreement with Medtronic plc to further the development of robotic assisted surgical technologies, as well as a separate license agreement with Medtronic in respect of certain intellectual property of Titan.

Item 5 Full Description of Material Change

Please see the press release attached as Schedule “A” hereto.

Item 6 Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

Item 7 Omitted Information

Not applicable.

Item 8 Executive Officer

The following executive officer is knowledgeable about the material change and may be contacted about this report:

Stephen Randall

Chief Financial Officer

(416) 548-7522 (ext. 152)

Email:stephen@titanmedicalinc.com

Website:www.titanmedicalinc.com

Item 9 Date of Report

June [4], 2020

SCHEDULE “A”

See attached news release.